Publication | Closed Access
Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse‐free survival
22
Citations
9
References
2010
Year
Patients suffering from palmar hyperhidrosis have a longer lasting disease, and a length of disease more than 20 years in these patients influences the RFS after BTX-A treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1